Juliane Mills, Director of Scientific Affairs, has a comprehensive understanding of drug development from the laboratory to the patient’s bedside from over 20 years of experience in various scientific roles in academic institutions and industry. She has extensive experience in the operational strategy and scientific design of various study types, such as disease and product registries, post-authorization safety studies (PASS), non-interventional studies, biomarker studies, and chart reviews.